SCHEMBL26548692

SCHEMBL26548692

FC(F)(F)c1cc(-c2ccc3ccc(-c4ccc(-c5ccc6ccccc6c5)nc4)cc3c2)cc(C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.42
CYP11B1 P15538 4/20 0.42
CYP11B2 P19099 4/20 0.42
CYP17A1 P05093 1/20 0.42
CYP19A1 P11511 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
MAOB P27338 1/20 0.40
CYP1A2 P05177 2/20 0.39
PARP1 P09874 1/20 0.38
KDM4E B2RXH2 3/20 0.38
MAPT P10636 3/20 0.38
ALOX5AP P20292 1/20 0.38
FEN1 P39748 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548179 0.99 CYP11B1 (0.43) KDM1ACYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL26548862 0.91 KDM1A (0.49) KDM1ATDP1HSD17B1HSD17B2MAOB
SCHEMBL26549195 0.91 PIK3CD (0.39) KDM1ACYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL26548689 0.90 KIF11 (0.43) KDM1ACYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL26548727 0.90 PIK3CD (0.43) KDM1ATDP1PARP1NPC1RAB9A
SCHEMBL26548176 0.89 KIF11 (0.44) KDM1ACYP11B1CYP11B2CYP17A1CYP19A1
SCHEMBL26548847 0.89 TDO2 (0.45) KDM1ACYP11B1CYP11B2TDP1HSD17B1
SCHEMBL26548215 0.88 PIK3CD (0.44) KDM1ATDP1NPC1RAB9A
SCHEMBL26548363 0.87 IDO1 (0.46) KDM1ACYP11B1CYP11B2TDP1HSD17B1
SCHEMBL26548708 0.86 SMN1; SMN2 (0.43) KDM1ACYP11B1CYP11B2CYP17A1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 KDM1A 114/4885CYP11B1 1676/4885CYP11B2 1913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.